108 related articles for article (PubMed ID: 5199396)
1. [Deterioration of parenterals due to compounding].
Kyakui N
Kango Gijutsu; 1970 Feb; ():67-74. PubMed ID: 5199396
[No Abstract] [Full Text] [Related]
2. [Study of compounding changes in parenteral injections by thin-layer chromatography. 1].
Tanaka K; Sakamoto Y; Nakai T
Iryo; 1968 Oct; 22(10):1109-14. PubMed ID: 4885315
[No Abstract] [Full Text] [Related]
3. [On the stability of parenterals at the time of compounding].
Kodama M; Ogata T
Iryo; 1969 Feb; 23(2):269-72. PubMed ID: 5803154
[No Abstract] [Full Text] [Related]
4. Large scale manufacture of parenterals.
Hempel HE
Bull Parenter Drug Assoc; 1976; 30(2):88-95. PubMed ID: 949565
[No Abstract] [Full Text] [Related]
5. Incompatibilities in large volume parenterals.
Bergman HD
Drug Intell Clin Pharm; 1977 Jun; 11(6):345-60. PubMed ID: 10297006
[No Abstract] [Full Text] [Related]
6. Parenteral incompatibilities--past, present and future.
Parker EA; Boomer RJ; Bell SC
Bull Parenter Drug Assoc; 1967; 21(6):197-207. PubMed ID: 6078886
[No Abstract] [Full Text] [Related]
7. A comparison of the pump syringe method with other methods for adding potassium chloride to Travenol large-volume parenterals.
Moeller KA; Clyne KE
Hosp Pharm; 1980 Dec; 15(12):605-7. PubMed ID: 10249421
[No Abstract] [Full Text] [Related]
8. A comparison of premixed and non-premixed potassium chloride large-volume parenterals.
Turco SJ
Hosp Pharm; 1979 Dec; 14(12):720-2. PubMed ID: 10309085
[No Abstract] [Full Text] [Related]
9. Cost and time required to add potassium chloride to large-volume parenterals.
Turco SJ
Hosp Pharm; 1979 Dec; 14(12):718-9. PubMed ID: 10309084
[No Abstract] [Full Text] [Related]
10. Drug additive compatibility--a manufacturer's concern.
Nedich RL
Bull Parenter Drug Assoc; 1973; 27(5):228-33. PubMed ID: 4201030
[No Abstract] [Full Text] [Related]
11. Mixing drugs with intravenous infusions.
Drug Ther Bull; 1970 Jul; 8(14):53-6. PubMed ID: 5451629
[No Abstract] [Full Text] [Related]
12. Parenteral development of clindamycin-2-phosphate.
Riebe KW; Oesterling TO
Bull Parenter Drug Assoc; 1972; 26(3):139-46. PubMed ID: 5035118
[No Abstract] [Full Text] [Related]
13. Hazards surround I.V. admixtures.
Dinel B
Hosp Adm Can; 1978 Sep; 20(9):21, 23. PubMed ID: 10239185
[No Abstract] [Full Text] [Related]
14. [On the thin-layer chromatography study of the newly adapted parenterals at the Nagoya National Hospital].
Ninomiya E; Usami H; Yamada H; Morikawa A; Matsuyama K
Iryo; 1969 Feb; 23(2):273-80. PubMed ID: 5803155
[No Abstract] [Full Text] [Related]
15. Low temperature vacuum drying of sterile parenterals from ethanol.
Flamberg DW; Francis DL; Morgan SL; Wickes GF
Bull Parenter Drug Assoc; 1970; 24(5):209-17. PubMed ID: 5471331
[No Abstract] [Full Text] [Related]
16. Panel discussion: hospital intravenous additive programs. I. An analysis of a hospital's I.V. additive service.
Schwarz MA
Bull Parenter Drug Assoc; 1969; 23(2):78-80. PubMed ID: 5776422
[No Abstract] [Full Text] [Related]
17. Continuous intravenous administration of drugs.
Paris P; Hans P; Lamy M
Acta Anaesthesiol Belg; 1983 Jun; 34(2):109-15. PubMed ID: 6613510
[TBL] [Abstract][Full Text] [Related]
18. Continuous versus intermittent intravenous antibiotics.
Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663
[No Abstract] [Full Text] [Related]
19. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals.
Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471
[TBL] [Abstract][Full Text] [Related]
20. Recommended standards of practice, policies, and procedures for intravenous therapy. National Coordinating Committee on Large Volume Parenterals.
Am J Hosp Pharm; 1980 May; 37(5):660-3. PubMed ID: 7386473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
